Press-release for stocks in the manufacturing sector

Prices are updated after-hours

approved sector : Manufacturing

save search

Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-04-23 (Crawled : 00:00) - prnewswire.com
ALPMY | News | $9.47 -0.21% -1.11% 400K

Manufacturing

| -0.21% | O: -1.05% H: 0.85% C: 0.85%
TAK | News | $13.23 -1.12% 0.0% 920K

Health Technology

| -0.86% | O: -0.19% H: 0.08% C: -0.68%
granted approval cancer treatment for

ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Published: 2024-04-23 (Crawled : 07:00) - biospace.com/
IBRX | $4.82 -12.2% -14.02% 7.4M

Manufacturing

| -8.63% | O: 16.59% H: 0.65% C: -10.73%
il-15 anktiva fda agonist approval bladder cancer for

Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
Published: 2024-04-11 (Crawled : 17:00) - biospace.com/
KPRX | $0.5058 -12.72% -14.98% 290K

Manufacturing

| -14.26% | O: 3.23% H: 0.16% C: -1.79%
granted approval pharmaceuticals research for grant trial foundation study

Rail Vision Received Approval from Alstom to Install the AI Main Line system on its Locomotives
Published: 2024-03-26 (Crawled : 13:30) - globenewswire.com
RVSN | $1.11 0.91% 0.0% 590K

n/a

| -53.75% | O: 7.5% H: 0.0% C: -14.53%
ALSMY | News | $1.6 -1.84% -1.78% 470K

Manufacturing

| 14.29% | O: 0.71% H: 1.42% C: 1.42%
approval system vision

Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer
Published: 2024-03-26 (Crawled : 12:00) - prnewswire.com
ALPMY | News | $9.47 -0.21% -1.11% 400K

Manufacturing

| -13.12% | O: -1.65% H: 3.36% C: 3.17%
japan approved cancer treatment

Power Solutions International Approves Use of Hydrotreated Vegetable Oil (HVO) in its Diesel Engine Line
Published: 2024-03-20 (Crawled : 14:00) - globenewswire.com
PSIX | $2.25 2.27% 56.25% 3.8K

Manufacturing

| 2.74% | O: -1.37% H: 0.19% C: -7.18%
international solutions oil

Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
PLUR | $5.09 1.8% 0.2% 12K

Manufacturing

| 403.96% | O: 0.0% H: 0.99% C: -4.1%
patent approval cell technology

Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector
Published: 2024-03-01 (Crawled : 15:00) - biospace.com/
MNKKQ | $0.02

Manufacturing

| Email alert Add to watchlist
MNK | $0.3402 -0.06% 540K

n/a

| Email alert Add to watchlist
MNKPF | $17.25

n/a

| Email alert Add to watchlist
MNKTQ | $0.12 -66.67% 39K

Manufacturing

| Email alert Add to watchlist
acthar fda drug approval gel application

PetVivo Holdings, Inc. Approved to Dual List on Upstream
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
PETV 4 | $0.7882 -6.17% -2.15% 29K

Manufacturing

| -33.05% | O: 0.01% H: 1.69% C: -0.01%
approved

Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
Published: 2024-02-20 (Crawled : 12:30) - globenewswire.com
GRCL | $10.25 -0.29% 6.4M

Manufacturing

| 0.39% | O: 0.05% H: 0.69% C: 0.44%
biotechnologies approval agreement

Stellantis Approves Share Buyback Program
Published: 2024-02-15 (Crawled : 08:00) - globenewswire.com
STLA | $24.86 -0.4% 0.72% 4.8M

Manufacturing

| 1.93% | O: 4.18% H: 2.72% C: 2.28%
program

Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
Published: 2024-02-14 (Crawled : 12:30) - prnewswire.com
IINN | $1.93 3.76% 3.38% 130K

Manufacturing

| 101.04% | O: 86.46% H: 9.5% C: -27.37%
first patent approval blood system

Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (Duchenne)
Published: 2024-02-13 (Crawled : 15:00) - biospace.com/
EWTX | $16.11 2.94% 2.67% 530K

Manufacturing

| -14.99% | O: -2.9% H: 2.99% C: 2.77%
edg-5506 fda treatment designation duchenne

Deep Medicine Shareholders Approve TruGolf Merger
Published: 2024-01-26 (Crawled : 14:30) - spacfeed.com
NVVE | News | $0.729 0.14% -1.75% 26K

Manufacturing

| -85.34% | O: -19.68% H: 3.88% C: -20.5%

Forbes-Approved: CareCloud is Streamlining Healthcare with Smart Technology for All Practices
Published: 2024-01-24 (Crawled : 14:00) - globenewswire.com
CCLD | $1.11 -2.63% 1.72% 15K

Manufacturing

| -11.9% | O: -4.76% H: 9.17% C: 5.83%
smart technology

Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
Published: 2024-01-17 (Crawled : 12:30) - globenewswire.com
IXHL | $2.26 -0.88% -1.29% 30K

Manufacturing

| -49.21% | O: 7.19% H: 0.0% C: -6.29%
ihl-42 drug approval ihl-42x trial

Proterra Receives Court Approval for Sale of Proterra Transit Business Line
Published: 2024-01-08 (Crawled : 22:00) - globenewswire.com
PTRAQ | $0.012 16.67% 310K

Manufacturing

| -47.83% | O: 26.09% H: 0.34% C: -13.45%
MC | $53.99 -1.12% 0.0% 860K

Finance

| -3.15% | O: -1.78% H: 0.24% C: -0.73%
business approval proterra

Standard BioTools Stockholders Approve Merger with SomaLogic
Published: 2024-01-05 (Crawled : 04:00) - globenewswire.com
LAB | $2.42 -5.47% -5.79% 2.3M

Manufacturing